anti-tirzepatide antibodies Tirzepatide and autoimmune disease: what the research actually shows Tirzepatide (Mounjaro)

Weight loss outcomes differ based on individual factors such as starting weight, adherence, and lifestyle habits

P = .001) No significant effect on mental QoL or PANSS-6 scores Adverse Effects GI symptoms more frequent in semaglutide group Slightly higher hospitalization rates in semaglutide group No difference in the number of serious adverse events between groups Clinical Implications This study confirms that semaglutide is safe and highly effective for improving metabolic health in patients with schizophrenia receiving antipsychotics

The study also included conducting biochemical tests that included zinc, copper and iron

52, 978980.10.1111/j.1471-4159.1989.tb02550.x 203 PizziM.RibolaM.ValerioA.MemoM.SpanoP

20 May 2024